The National Financial Burden of Hospitalization of Diabetes in Iran

  • Shahram Ghaffari
  • Seyed Ebrahim Hashemi
  • Haleh Atabaki
Keywords: Hospitalization Cost, Diabetes, Health economics, Iran

Abstract

Purpose: To determine hospitalization cost of diabetes in Iran.

Methods: The cost-of-illness analysis, using bottom-up and prevalence approach has been conducted. Cost information of 4002 diabetic inpatients, based on ICD-10 coding standard, were collected and analyzed.

Results: The study shows that the mean age of diabetic patients was 58.3 years and the average length of stay was 6.2. The average cost of diabetic patients irrespective of their type of diabetes was US $716. Every one day of hospitalization of a diabetic patient imposes US$117 on a typical buyer of service. With 4% prevalence rate of diabetes and presuming that diabetes raises the event of hospitalization by at least 3 times, about 884,591 diabetic patients were estimated to be hospitalized in 2009, in Iran. For buyers and based on the national tariff, the diabetes inpatients cost was amounted to US $633.97 million, in 2009, while for providers this amount can increase up to US $887.31 million. Diabetes hospitalizations consume 3.2 to 4.5 percent of the total health expenditure in Iran.

Conclusion: Diabetes hospitalization imposes a significant financial burden on individual, insurer, government and the society. This burden will increase as the prevalence of diabetes as well as the cost and rate of hospitalization increases.

References

Zhang P, Zhang X, Brown JB, Vistisen D, Sicree RA, Shaw J, et al: Economic impact of diabetes. In: Unwin N, Whiting D, Gan D, Jacqmain O, Ghyoot G, editors. IDF Diabetes Atlas. 4th ed. Brussels: International Diabetes Federation; 2010.

Diabetes Quebec, C.D.A., Canadian medical association, American diabetes association. What is diabetes? 2004.

Larijani M, et al: The assessment of economic cost of diabetes. Iranian South Medical Journal 2001. 4(2): 157-62.

Solli O, Jenssen T, Kristiansen IS: Diabetes: cost of illness in Norway. BMC Endocrine Disorders 2010. 10(15). doi: 10.1186/1472-6823-10-15.

Akkanen MJ: Inpatient hospital care and its costs among type 1 diabetic patients in Finland– a nationwide longitudinal study. Diabetes Unit of the Department of Health Promotion and Chronic Disease Prevention,National Public Health Institute, Helsinki, Finland; 2007.

Bjo¨rk S: The cost of diabetes and diabetes care. Diabetes Res Clin Pract 2001, 54 (Suppl 1): 13-8. doi: 10.1016/S0168-8227(01)00304-7.

Nakamura K, Okamura T, Kanda H, Hayakawa T, Murakami Y, Okayama A, et al: Medical expenditure for diabetic patients: a 10-year follow-up study of National Health Insurance in Shiga, Japan. Public Health 2008, 122(11): 1226-8. doi: 10.1016/j.puhe.2007.12.004.

Hogan P, Dall T, Nikolov P; American Diabetes Association. Economic cost of diabetes in US in 2002. Diabetes Care 2003, 26(3): 917-32. doi: 10.2337/diacare.26.3.917

Clarke PM, Glasziou P, Patel A, Chalmers J, Woodward M, Harrap SB, et al: Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis. PLoS Medicine 2010,7(2). doi: 10.1371/journal.pmed.1000236

International Diabetes Fedration: Middle East and North Africa. [http://archive.diabetesatlas.org/content/middle-east-and-north-africa.]

Larijani, M., et al., The prevalence of type 2 diabetes in Iran in 2000. Diabetes and Lipid 2005. 4(3).

Olveira-Fuster G, Olvera-Márquez P, Carral-Sanlaureano F, González-Romero S, Aguilar-Diosdado M, Soriguer-Escofet F: Excess hospitalizations, hospital days, and inpatient costs among people with diabetes in Andalusia, Spain. Diabetes Care 2004. 27(8): 1904-9. doi: 10.2337/diacare.27.8.1904.

Tomlin AM, Dovey SM, Tilyard MW: Risk factors for hospitalization due to diabetes complications. Diabetes Res Clin Pract 2008, 80(2): 244-52. doi: 10.1016/j.diabres.2007.12.017.

Wang W, Fu C, Zhuo H, Luo J, Xu B: Factors affecting costs and utilization of type 2 diabetes healthcare: a cross-sectional survey among 15 hospitals in urban China. BMC Health Serv Res 2010, 10(1): 244. doi: 10.1186/1472-6963-10-244.

Gagliardino JJ, Martella A, Etchegoyen GS, Caporale JE, Guidi ML, Olivera EM, et al: Hospitalization and re-hospitalization of people with and without diabetes in La Plata, Argentina: comparison of their clinical characteristics and costs. Diabetes Res Clin Pract 2004, 65(1): 51-9. doi: 10.1016/j.diabres.2003.11.011.

Tomlin AM, Tilyard MW, Dovey SM, Dawson AG: Hospital admissions in diabetic and non-diabetic patients: A case-control study. Diabetes Res Clin Pract 2006, 73(3): 260-7. doi: 10.1016/j.diabres.2006.01.008.

Bo S, Ciccone G, Grassi G, Gancia R, Rosato R, Merletti F, et al: Patients with type 2 diabetes had higher rates of hospitalization than the general population. J Clin Epidemiol 2004, 57(11): 1196-201. doi: 10.1016/j.jclinepi.2004.02.015.

American Diabetes Association: Economic cost of diabetes in the US in 2007. Diabetes Care 2008, 31(3): 596-615. doi: 10.2337/dc08-9017.

van der Linden MW, Plat AW, Erkens JA, Emneus M, Herings RM: Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004. Value Health 2009, 12(6):909-14. doi: 10.1111/j.1524-4733.2009.00506.x.

Esteghamati A, Khalilzadeh O, Anvari M, Meysamie A, Abbasi M, Forouzanfar M, et al: The economic cost of diabetes: a population based study in Tehran, Iran. Diabetologia 2009, 52(8):1520-7. doi: 10.1007/s00125-009-1398-4.

Ettaro L, Songer TJ, Zhang P, Engelgau MM: Cost-of-Illness Studies in Diabetes Mellitus. Pharmacoeconomics 2004, 22(16): 149-64.

Akobundu E, Ju J, Blatt L, Mullins CD: Cost-of-illness studies: a review of current method. Pharmacoeconomics 2006, 24(9): 869-90.

Segel JE: Cost-of-Illness studies-A primer. RTI international; 2006. pp. 1–39. (RTI -UNC Center of Excellence in Health Promotion Economics). [http://www.rti.org/pubs/coi_primer.pdf.]

Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011.

De Berardis G, D'Ettorre A, Graziano G, Lucisano G, Pellegrini F, Cammarota S, et al: The burden of hospitalization related to diabetes mellitus: A population-based study. Nutr Metab Cardiovasc Dis 2012, 22(7):605-12. doi: 10.1016/j.numecd.2010.10.016.

Kim S, Boye KS: Excessive hospitalizations and its associated economic burden among people with diabetes in the United States. Value Health 2009, 12(2):267-72. doi: 10.1111/j.1524-4733.2008.00443.x.

Iran Central Bank: Refrence ExRates. 2012 [ http://www.cbi.ir/exrates/rates_fa.aspx.]

Kapur A: Economic analysis of diabetes care. Indian J Med Res 2007, 125(3): 473-82.

Jönsson B, CODE-2 Advisory Board: Revealing the cost of Type II diabetes in Europe. Diabetologia 2002, 45(7):S5-12.

Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, et al: Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87(3):293-301. doi: 10.1016/j.diabres.2010.01.026.

Published
2012-07-07
Section
Research Articles